Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 12,461 | 0 | 0 | 0 | 0 |
| Gross Profit | 12,461 | N/A | N/A | N/A | N/A |
| Operating Expenses | 80,426 | 65,160 | 191,940 | 19,818 | 12,680 |
| Operating Income | -67,965 | -65,160 | -191,940 | -19,818 | -12,680 |
| Other Income | 391 | 195 | 69 | 0 | -10,089 |
| Pre-tax Income | -67,574 | -64,965 | -191,871 | -19,818 | -22,769 |
| Income Tax | -1,616 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -65,958 | -64,965 | -191,871 | -19,818 | -22,769 |
| Net Income | $-65,958 | $-64,965 | $-191,871 | $-19,818 | $-22,769 |
| EPS Basic Total Ops | -0.79 | -0.79 | -19.11 | -10.50 | -5.80 |
| EPS Basic Continuous Ops | -0.79 | -0.79 | -21.06 | -2.89 | -3.46 |
| EPS Diluted Total Ops | -0.79 | -0.79 | -19.11 | -10.50 | -5.80 |
| EPS Diluted Continuous Ops | -0.79 | -0.79 | -21.06 | -2.89 | -3.46 |
| EBITDA(a) | $-66,796 | $-64,119 | $-191,628 | $-19,744 | $-12,680 |